ANGLE’s Parsortix system has the potential to deliver profound improvements in clinical and health economic outcomes in the treatment and diagnosis of various forms of cancer.”
Andrew Newland
Chief Executive

The Parsortix™ system is simple, effective and affordable

  • Captures a high proportion of CTCs
  • Can be used with all solid tumor cancers (including breast, prostate, lung, and colorectal)
  • CTCs can be easily harvested (recovered from system) for analysis
  • High purity of CTCs (i.e. very low background contamination from white blood cells) allowing direct molecular analysis of harvested cells
  • Very simple operation with minimal user intervention required

System does not use antibodies to capture cells

  • Antibody systems miss key target cells such as mesenchymal cells
  • Antibody systems do not work well for some cancers such as ovarian cancer
  • Antibody systems are complicated and expensive

System does not use membranes to capture cells

  • Membrane systems can clog up and have high background contamination
  • Membrane systems cannot easily harvest CTCs for analysis
QIAGEN Co-Marketing PartnershipRead more here